Royalty Pharma Plc (RPRX)
48.49
-0.21
(-0.43%)
USD |
NASDAQ |
Apr 16, 16:00
48.49
0.00 (0.00%)
After-Hours: 20:00
Royalty Pharma Research and Development Expense (Quarterly) : 51.00M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Zymeworks, Inc. | 31.24M |
| Johnson & Johnson | 4.268B |
| Biogen, Inc. | 434.00M |
| Revolution Medicines, Inc. | 292.61M |
| Corcept Therapeutics, Inc. | 64.86M |